Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

2372.87 (Glytoucan)

Id:6073d91d-c704-517c-9d5e-d67d6c6405c6

Glytoucan:G37420XW

Results found

Linked to

	Label	Description
	2372.87 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000013 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2372.87 has glycosequence GLYGEN.GLYCOSEQUENCE:G11721NX-GLYCOSEQ00190565 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2372.87 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000061 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2372.87 has glycosequence GLYGEN.GLYCOSEQUENCE:G77697FA-GLYCOSEQ00189205 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2372.87 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000017 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2372.87 has canonical residue n-glycan core b-d-glcpnac b Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2372.87 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000060 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2372.87 has glycosequence GLYGEN.GLYCOSEQUENCE:G81910BW-GLYCOSEQ00028099 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2372.87 has glycosequence GLYGEN.GLYCOSEQUENCE:G42830YF-GLYCOSEQ00113280 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2372.87 has glycosequence GLYGEN.GLYCOSEQUENCE:G10726AO-GLYCOSEQ00013699 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2372.87 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000013 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2372.87 has glycosequence GLYGEN.GLYCOSEQUENCE:G11721NX-GLYCOSEQ00190565 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2372.87 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000061 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2372.87 has glycosequence GLYGEN.GLYCOSEQUENCE:G77697FA-GLYCOSEQ00189205 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2372.87 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000017 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2372.87 has canonical residue n-glycan core b-d-glcpnac b

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2372.87 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000060 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2372.87 has glycosequence GLYGEN.GLYCOSEQUENCE:G81910BW-GLYCOSEQ00028099 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2372.87 has glycosequence GLYGEN.GLYCOSEQUENCE:G42830YF-GLYCOSEQ00113280 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2372.87 has glycosequence GLYGEN.GLYCOSEQUENCE:G10726AO-GLYCOSEQ00013699 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.